Vascular Solutions LLC (VASC)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Vascular Solutions LLC (VASC) trades at $56.00 with AI Score 51/100 (Grade B). Vascular Solutions LLC specializes in the development, manufacturing, and marketing of medical devices for vascular and cardiac procedures. Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for VASC: VASC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates VASC against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
VASC: 2/4 perspectives are bullish. Dominant signal: Ray Dalio bullish.
Vascular Solutions LLC (VASC) Healthcare & Pipeline Overview
Vascular Solutions LLC operates within the medical device industry, providing specialized devices for vascular and cardiac procedures. With a focus on innovation and a gross margin of 66.8%, the company caters to interventional cardiology, interventional radiology, and vascular surgery, though its high P/E ratio of 91.53 warrants investor consideration.
What Is the Investment Thesis for VASC?
Vascular Solutions LLC presents a focused investment opportunity within the medical device sector, driven by its specialized product portfolio and commitment to innovation. The company's gross margin of 66.8% reflects efficient operations. However, the high P/E ratio of 91.53 suggests that the company may be overvalued relative to its earnings. Upcoming growth catalysts include expansion into new geographic markets and the introduction of innovative products. Potential risks include increasing competition from larger medical device companies and regulatory challenges associated with medical device approvals. Investors should carefully consider these factors when evaluating Vascular Solutions LLC.
Based on FMP financials and quantitative analysis
VASC Key Highlights
- Gross Margin of 66.8% indicates strong pricing power and efficient operations.
- Profit Margin of 7.1% reflects the company's ability to convert revenue into profit.
- Beta of 1.06 suggests that the stock's price is slightly more volatile than the market average.
- Focus on innovative medical devices for vascular and cardiac procedures positions the company for growth in specialized markets.
- No dividend yield may deter income-seeking investors.
Who Are VASC's Competitors?
VASC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MDT Medtronic plc | $80.33 | +0.10% | $103.13B | 56 |
| BSX Boston Scientific Corporation | $46.12 | -2.23% | $68.55B | 56 |
| ABT Abbott Laboratories | $88.17 | -1.65% | $153.58B | 48 |
| NPCE NeuroPace, Inc. | $15.89 | +0.32% | $541.75M | 65 |
| ATRWF Altius Renewable Royalties Corp. | $8.50 | +0.00% | $262.46M | 64 |
| LFTSF LifeTech Scientific Corporation | $0.23 | +0.00% | $1.03B | 63 |
| MYO Myomo, Inc. | $1.20 | -12.41% | $46.37M | 62 |
| IOBCF Ion Beam Applications S.A. | $19.36 | -3.68% | $567.79M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VASC's Key Strengths?
- Specialized product portfolio
- Strong gross margin
- Focus on innovation
- Established relationships with healthcare providers
What Are VASC's Weaknesses?
- High P/E ratio
- Limited scale compared to larger competitors
- Dependence on specific product lines
- No dividend yield
What Could Drive VASC Stock Higher?
- New product launches in interventional cardiology.
- Expansion into emerging markets.
- Increasing adoption of minimally invasive procedures.
- Positive clinical trial results for new devices.
What Are the Key Risks for VASC?
- Increasing competition from larger medical device companies.
- Regulatory hurdles for new product approvals.
- Economic downturns affecting hospital budgets.
- Technological advancements rendering existing products obsolete.
What Are the Growth Opportunities for VASC?
- Expansion into Emerging Markets: Vascular Solutions LLC has the opportunity to expand its presence in emerging markets, where demand for advanced medical devices is growing rapidly. These markets offer significant potential for revenue growth as healthcare infrastructure improves and access to advanced medical treatments increases. The company can leverage its existing product portfolio and establish strategic partnerships to penetrate these markets effectively. Timeline: Ongoing.
- New Product Development: Investing in research and development to create innovative medical devices can drive growth. Focusing on unmet clinical needs and leveraging technological advancements can lead to the development of novel products that capture market share. This includes exploring opportunities in areas such as drug-eluting devices and bioresorbable materials. Timeline: Ongoing.
- Strategic Acquisitions: Acquiring complementary businesses or technologies can accelerate growth and expand Vascular Solutions LLC's product offerings. Identifying companies with innovative products or strong market positions in adjacent areas can create synergies and enhance the company's competitive advantage. This can also provide access to new customer segments and distribution channels. Timeline: Ongoing.
- Increased Focus on Minimally Invasive Procedures: The trend towards minimally invasive procedures is expected to continue, driving demand for Vascular Solutions LLC's products. By focusing on developing devices that enable less invasive approaches, the company can capitalize on this trend and gain market share. This includes investing in training and education programs to promote the adoption of these techniques. Timeline: Ongoing.
- Partnerships with Healthcare Providers: Collaborating with hospitals and clinics to develop customized solutions and improve procedural outcomes can create long-term relationships and drive sales. This includes offering comprehensive service packages that include training, support, and data analysis to help healthcare providers optimize their use of Vascular Solutions LLC's products. Timeline: Ongoing.
What Opportunities Does VASC Have?
- Expansion into emerging markets
- New product development
- Strategic acquisitions
- Increased focus on minimally invasive procedures
What Threats Does VASC Face?
- Increasing competition
- Regulatory challenges
- Economic downturns
- Technological obsolescence
What Are VASC's Competitive Advantages?
- Specialized product portfolio
- Strong relationships with healthcare providers
- Commitment to innovation
- Proprietary technology
What Does VASC Do?
Vascular Solutions LLC is a medical device company focused on designing, manufacturing, and marketing innovative solutions for vascular and cardiac procedures. The company was founded with the goal of addressing unmet clinical needs in interventional cardiology, interventional radiology, and vascular surgery. Over the years, Vascular Solutions has developed a comprehensive portfolio of products used by physicians to perform minimally invasive procedures. These products include catheters, guidewires, introducers, and specialized kits designed to improve procedural outcomes and patient safety. Vascular Solutions has established a strong presence in the United States and also distributes its products internationally. The company's commitment to innovation is reflected in its ongoing research and development efforts, aimed at introducing new and improved devices to meet the evolving needs of the medical community. Despite a high P/E ratio, the company maintains a solid gross margin of 66.8%, indicating efficient operations and strong pricing power within its niche markets. The company continues to focus on expanding its product offerings and geographic reach to drive future growth.
What Products and Services Does VASC Offer?
- Develops medical devices for vascular procedures.
- Manufactures devices used in interventional cardiology.
- Markets products to hospitals and clinics.
- Provides solutions for interventional radiology.
- Offers specialized kits for vascular surgery.
- Focuses on minimally invasive procedures.
- Distributes products both domestically and internationally.
How Does VASC Make Money?
- Develops and manufactures specialized medical devices.
- Sells products directly to hospitals and clinics.
- Generates revenue through product sales.
- Invests in research and development to create new products.
What Industry Does VASC Operate In?
Vascular Solutions LLC operates in the medical device industry, which is characterized by continuous innovation and increasing demand for minimally invasive procedures. The market is competitive, with both large, established players and smaller, specialized companies vying for market share. Key trends include the development of advanced materials, the integration of digital technologies, and a growing emphasis on patient-specific solutions. Vascular Solutions LLC differentiates itself through its focus on specialized devices for vascular and cardiac procedures, allowing it to capture a niche segment within the broader medical device market.
Who Are VASC's Key Customers?
- Hospitals
- Clinics
- Interventional cardiologists
- Interventional radiologists
- Vascular surgeons
VASC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
VASC Latest News
No recent news available for VASC.
VASC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VASC.
Price Targets
Wall Street price target analysis for VASC.
VASC MoonshotScore
What does this score mean?
The MoonshotScore rates VASC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Vascular Solutions LLC Healthcare Stock: Key Questions Answered
What does Vascular Solutions LLC do?
Vascular Solutions LLC specializes in the development, manufacturing, and marketing of medical devices for vascular and cardiac procedures. The company offers a range of products, including catheters, guidewires, introducers, and specialized kits, designed to improve procedural outcomes and patient safety. These products are used by physicians in interventional cardiology, interventional radiology, and vascular surgery. The company operates both domestically and internationally, focusing on innovation and addressing unmet clinical needs within the medical community.
What are the main risks for VASC?
Vascular Solutions LLC faces several risks, including increasing competition from larger medical device companies with greater resources and broader product portfolios. Regulatory challenges associated with obtaining approvals for new medical devices can also pose a risk, as delays or denials can impact the company's growth prospects. Economic downturns may affect hospital budgets, leading to reduced demand for the company's products. Additionally, technological advancements could render existing products obsolete, requiring continuous investment in research and development to maintain competitiveness.
What are the key factors to evaluate for VASC?
Vascular Solutions LLC (VASC) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does VASC data refresh on this page?
VASC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven VASC's recent stock price performance?
Vascular Solutions LLC (VASC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider VASC overvalued or undervalued right now?
Valuing Vascular Solutions LLC (VASC) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying VASC?
Before investing in Vascular Solutions LLC (VASC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding VASC to a portfolio?
Key strength of Vascular Solutions LLC (VASC): Specialized product portfolio. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on limited information.
- AI analysis is pending and may provide further insights.